2IJO image
Deposition Date 2006-09-29
Release Date 2007-05-15
Last Version Date 2024-10-30
Entry Detail
PDB ID:
2IJO
Title:
Crystal Structure of the West Nile virus NS2B-NS3 protease complexed with bovine pancreatic trypsin inhibitor
Biological Source:
Source Organism:
West Nile virus (Taxon ID: 11082)
Bos taurus (Taxon ID: 9913)
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.30 Å
R-Value Free:
0.26
R-Value Work:
0.21
R-Value Observed:
0.21
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Polyprotein
Chain IDs:A
Chain Length:58
Number of Molecules:1
Biological Source:West Nile virus
Polymer Type:polypeptide(L)
Molecule:Polyprotein
Mutations:K104R
Chain IDs:B
Chain Length:192
Number of Molecules:1
Biological Source:West Nile virus
Polymer Type:polypeptide(L)
Molecule:Pancreatic trypsin inhibitor
Chain IDs:C (auth: I)
Chain Length:58
Number of Molecules:1
Biological Source:Bos taurus
Primary Citation
Structural evidence for regulation and specificity of flaviviral proteases and evolution of the Flaviviridae fold.
Protein Sci. 16 795 806 (2007)
PMID: 17400917 DOI: 10.1110/ps.072753207

Abstact

Pathogenic members of the flavivirus family, including West Nile Virus (WNV) and Dengue Virus (DV), are growing global threats for which there are no specific treatments. The two-component flaviviral enzyme NS2B-NS3 cleaves the viral polyprotein precursor within the host cell, a process that is required for viral replication. Here, we report the crystal structure of WNV NS2B-NS3pro both in a substrate-free form and in complex with the trypsin inhibitor aprotinin/BPTI. We show that aprotinin binds in a substrate-mimetic fashion in which the productive conformation of the protease is fully formed, providing evidence for an "induced fit" mechanism of catalysis and allowing us to rationalize the distinct substrate specificities of WNV and DV proteases. We also show that the NS2B cofactor of WNV can adopt two very distinct conformations and that this is likely to be a general feature of flaviviral proteases, providing further opportunities for regulation. Finally, by comparing the flaviviral proteases with the more distantly related Hepatitis C virus, we provide insights into the evolution of the Flaviviridae fold. Our work should expedite the design of protease inhibitors to treat a range of flaviviral infections.

Legend

Protein

Chemical

Disease

Primary Citation of related structures